predicts

4D Paths Physics-Inspired QPOR Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial

NEWTON, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through a novel,…

2 days ago

Avalara Predicts 2026 Will Reshape Global Business Through AI, Transparency, and Compliance Agility

New Avalara insights forecast how automation, regulation, and real-time data will impact tax, trade, and digital operations worldwide DURHAM, N.C.,…

3 weeks ago